PRECISION OPTICS CORPORATION, INC. Cost of Goods Sold (Deprecated 2018-01-31)
PRECISION OPTICS CORPORATION, INC. (POCI) reported Cost of Goods Sold (Deprecated 2018-01-31) of $512.55 thousand for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-14.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-02-14
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $512.55K, a 13.10% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $642.00K, a 5.93% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $540.08K, a 16.08% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $705.06K, a 18.71% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $2.38M, a 19.96% decline from fiscal 2016.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $2.97M, a 4.47% decline from fiscal 2015.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $3.11M, a 9.24% increase from fiscal 2014.
- PRECISION OPTICS CORPORATION, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $2.85M, a 52.81% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $512.55K 10-Q · filed 2018-02-14 | $1.15M 10-Q · filed 2018-02-14 | $1.69M derived: sum of 3 quarters · filed 2018-02-14 | $2.40M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-09-30 | $642.00K 10-Q · filed 2017-11-14 | $1.18M derived: sum of 2 quarters · filed 2017-11-14 | $1.89M derived: sum of 3 quarters · filed 2017-11-14 | $2.34M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $540.08K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $1.25M derived: sum of 2 quarters · filed 2017-09-28 | $1.70M derived: sum of 3 quarters · filed 2018-02-14 | $2.38M 10-K · filed 2017-09-28 |
| 2017-03-31 | $705.06K 10-Q · filed 2017-05-15 | $1.16M derived: sum of 2 quarters · filed 2018-02-14 | $1.84M 10-Q · filed 2017-05-15 | $2.48M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $453.18K 10-Q · filed 2018-02-14 | $1.14M 10-Q · filed 2018-02-14 | $1.78M derived: sum of 3 quarters · filed 2018-02-14 | $2.65M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | $682.50K 10-Q · filed 2017-11-14 | $1.33M derived: sum of 2 quarters · filed 2017-11-14 | $2.19M derived: sum of 3 quarters · filed 2017-11-14 | $2.93M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $643.55K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $1.51M derived: sum of 2 quarters · filed 2017-09-28 | $2.25M derived: sum of 3 quarters · filed 2017-09-28 | $2.97M 10-K · filed 2017-09-28 |
| 2016-03-31 | $867.29K 10-Q · filed 2017-05-15 | $1.61M derived: sum of 2 quarters · filed 2017-05-15 | $2.33M 10-Q · filed 2017-05-15 | $3.08M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $737.75K 10-Q · filed 2017-02-14 | $1.46M 10-Q · filed 2017-02-14 | $2.22M derived: sum of 3 quarters · filed 2017-02-14 | $3.05M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-09-30 | $726.09K 10-Q · filed 2016-11-14 | $1.48M derived: sum of 2 quarters · filed 2016-11-14 | $2.31M derived: sum of 3 quarters · filed 2016-11-14 | $3.12M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $752.21K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $1.58M derived: sum of 2 quarters · filed 2016-09-28 | $2.40M derived: sum of 3 quarters · filed 2016-09-28 | $3.11M 10-K · filed 2016-09-28 |
| 2015-03-31 | $828.96K 10-Q · filed 2016-05-16 | $1.64M derived: sum of 2 quarters · filed 2016-05-16 | $2.36M 10-Q · filed 2016-05-16 | $3.12M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $814.04K 10-Q · filed 2016-02-16 | $1.53M 10-Q · filed 2016-02-16 | $2.29M derived: sum of 3 quarters · filed 2016-02-16 | $2.93M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-09-30 | $718.58K 10-Q · filed 2015-11-12 | $1.48M derived: sum of 2 quarters · filed 2015-11-12 | $2.12M derived: sum of 3 quarters · filed 2015-11-12 | $2.92M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $756.67K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $1.40M derived: sum of 2 quarters · filed 2015-10-13 | $2.20M derived: sum of 3 quarters · filed 2015-10-13 | $2.85M 10-K · filed 2015-10-13 |
| 2014-03-31 | $644.22K 10-Q · filed 2015-05-14 | $1.45M derived: sum of 2 quarters · filed 2015-05-14 | $2.09M 10-Q · filed 2015-05-14 | $2.61M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $802.30K 10-Q · filed 2015-02-17 | $1.45M 10-Q · filed 2015-02-17 | $1.97M derived: sum of 3 quarters · filed 2015-02-17 | $2.46M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-09-30 | $647.19K 10-Q · filed 2014-11-13 | $1.16M derived: sum of 2 quarters · filed 2014-11-13 | $1.66M derived: sum of 3 quarters · filed 2014-11-13 | $2.08M derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | $516.48K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $1.01M derived: sum of 2 quarters · filed 2014-09-29 | $1.43M derived: sum of 3 quarters · filed 2014-09-29 | $1.87M 10-K · filed 2014-09-29 |
| 2013-03-31 | $496.58K 10-Q · filed 2014-05-15 | $914.91K derived: sum of 2 quarters · filed 2014-05-15 | $1.35M 10-Q · filed 2014-05-15 | $1.82M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $418.33K 10-Q · filed 2014-02-14 | $852.25K 10-Q · filed 2014-02-14 | $1.33M derived: sum of 3 quarters · filed 2014-02-14 | $1.70M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-09-30 | $433.93K 10-Q · filed 2013-11-14 | $909.07K derived: sum of 2 quarters · filed 2013-11-14 | $1.28M derived: sum of 3 quarters · filed 2013-11-14 | $1.66M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $475.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30 | $847.08K derived: sum of 2 quarters · filed 2013-09-30 | $1.23M derived: sum of 3 quarters · filed 2013-09-30 | $1.59M 10-K · filed 2013-09-30 |
| 2012-03-31 | $371.94K 10-Q · filed 2013-05-15 | $754.39K derived: sum of 2 quarters · filed 2013-05-15 | $1.12M 10-Q · filed 2013-05-15 | $1.58M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $382.45K 10-Q/A · filed 2013-02-15 | $747.91K 10-Q/A · filed 2013-02-15 | $1.21M derived: sum of 3 quarters · filed 2013-02-15 | $1.57M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-09-30 | $365.45K 10-Q · filed 2012-11-14 | $822.81K derived: sum of 2 quarters · filed 2012-11-14 | $1.18M derived: sum of 3 quarters · filed 2012-11-14 | $1.53M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $457.36K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $818.38K derived: sum of 2 quarters · filed 2012-10-26 | $1.16M derived: sum of 3 quarters · filed 2012-10-26 | $1.49M 10-K/A · filed 2012-10-26 |
| 2011-03-31 | $361.02K 10-Q · filed 2012-05-15 | $704.00K derived: sum of 2 quarters · filed 2012-05-15 | $1.04M 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $342.98K 10-Q · filed 2012-02-14 | $674.64K 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | $331.67K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |